Cargando…
Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
Although many patients are cured from prostate cancer (PCa) by surgery only, there are still patients who will experience rising prostate-specific antigen (PSA) levels after surgery, a condition known as biochemical recurrence (BCR). Novel protein prognostic markers in PCa tissue might enable findin...
Autores principales: | Rodríguez-Blanco, Giovanny, Zeneyedpour, Lona, Duijvesz, Diederick, Hoogland, A. Marije, Verhoef, Esther I., Kweldam, Charlotte F., Burgers, Peter C., Smitt, Peter Sillevis, Bangma, Chris H., Jenster, Guido, van Leenders, Geert J.L.H., Dekker, Lennard J.M., Luider, Theo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284859/ https://www.ncbi.nlm.nih.gov/pubmed/30559929 http://dx.doi.org/10.18632/oncotarget.26342 |
Ejemplares similares
-
Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer
por: Duijvesz, Diederick, et al.
Publicado: (2019) -
Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
por: Böttcher, René, et al.
Publicado: (2015) -
An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
por: Dekker, Lennard J. M., et al.
Publicado: (2010) -
Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma
por: Zeneyedpour, Lona, et al.
Publicado: (2022) -
Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer
por: Hoogland, A. Marije, et al.
Publicado: (2016)